180 Life Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

180 Life Stock Summary

180 Life competes with Zura Bio, Phio Pharmaceuticals, Sonnet Biotherapeutics, Cardio Diagnostics, and Altamira Therapeutics. 1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company was incorporated in 2016 and is headquartered in Palo Alto, California. 180 Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.

180 Life Key Financial Ratios

180 Life Key Balance Sheet Accounts

180 Life Key Income Statement Accounts

180 Life Key Cash Accounts

180 Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining 180 Life's current stock value. Our valuation model uses many indicators to compare 180 Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across 180 Life competition to find correlations between indicators driving 180 Life's intrinsic value. More Info.180 Life Sciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, 180 Life's Return On Equity is most likely to increase significantly in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value 180 Life by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

180 Life Sciences Systematic Risk

Today, most investors in 180 Life Stock are looking for potential investment opportunities by analyzing not only static indicators but also various 180 Life's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of 180 Life growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of 180 Life help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of 180 Life Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of 180 Life Sciences based on widely used predictive technical indicators. In general, we focus on analyzing 180 Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build 180 Life's daily price indicators and compare them against related drivers.

When running 180 Life's price analysis, check to measure 180 Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 180 Life is operating at the current time. Most of 180 Life's value examination focuses on studying past and present price action to predict the probability of 180 Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 180 Life's price. Additionally, you may evaluate how the addition of 180 Life to your portfolios can decrease your overall portfolio volatility.